Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells
Giusy Tornillo,
Catherine Knowlson,
Howard Kendrick,
Joe Cooke,
Hasan Mirza,
Iskander Aurrekoetxea-Rodríguez,
Maria d.M. Vivanco,
Niamh E. Buckley,
Anita Grigoriadis,
Matthew J. Smalley
Affiliations
Giusy Tornillo
European Cancer Stem Cell Research Institute, School of Biosciences, Hadyn Ellis Building, Cardiff University, Cardiff CF24 4HQ, UK
Catherine Knowlson
Centre for Cancer Research and Cell Biology, Queens University Belfast, 97 Lisburn Rd, Belfast BT9 7AE, UK
Howard Kendrick
European Cancer Stem Cell Research Institute, School of Biosciences, Hadyn Ellis Building, Cardiff University, Cardiff CF24 4HQ, UK
Joe Cooke
European Cancer Stem Cell Research Institute, School of Biosciences, Hadyn Ellis Building, Cardiff University, Cardiff CF24 4HQ, UK
Hasan Mirza
School of Cancer & Pharmaceutical Sciences, CRUK King’s Health Partners Centre, King’s College London, Innovation Hub, Comprehensive Cancer Centre at Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK
Iskander Aurrekoetxea-Rodríguez
Center for Cooperative Research in Biosciences, CIC bioGUNE, 48160 Derio, Spain
Maria d.M. Vivanco
Center for Cooperative Research in Biosciences, CIC bioGUNE, 48160 Derio, Spain
Niamh E. Buckley
School of Pharmacy and Centre for Cancer Research and Cell Biology, Queens University Belfast, 97 Lisburn Rd, Belfast BT9 7AE, UK
Anita Grigoriadis
School of Cancer & Pharmaceutical Sciences, CRUK King’s Health Partners Centre, King’s College London, Innovation Hub, Comprehensive Cancer Centre at Guy’s Hospital, Great Maze Pond, London SE1 9RT, UK
Matthew J. Smalley
European Cancer Stem Cell Research Institute, School of Biosciences, Hadyn Ellis Building, Cardiff University, Cardiff CF24 4HQ, UK; Corresponding author
Summary: The SRC-family kinase LYN is highly expressed in triple-negative/basal-like breast cancer (TNBC) and in the cell of origin of these tumors, c-KIT-positive luminal progenitors. Here, we demonstrate LYN is a downstream effector of c-KIT in normal mammary cells and protective of apoptosis upon genotoxic stress. LYN activity is modulated by PIN1, a prolyl isomerase, and in BRCA1 mutant TNBC PIN1 upregulation activates LYN independently of c-KIT. Furthermore, the full-length LYN splice isoform (as opposed to the Δaa25–45 variant) drives migration and invasion of aggressive TNBC cells, while the ratio of splice variants is informative for breast cancer-specific survival across all breast cancers. Thus, dual mechanisms—uncoupling from upstream signals and splice isoform ratios—drive the activity of LYN in aggressive breast cancers. : Tornillo et al. show that in aggressive breast cancers, LYN activity is deregulated by a change in patterns of splice isoform expression. In BRCA1-dysfunctional breast cancers, LYN activity is upregulated by a prolyl isomerase (PIN1) that is normally repressed by BRCA1. Keywords: BRCA1, LYN kinase, triple-negative/basal-like breast cancer, PIN1, ESRP1, c-KIT